COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year

Article summarises pathophysiology of COVID-19 coagulopathy in the context of patients who are ambulant, admitted to hospital, and critically or non-critically ill, and those post-discharge. It reviews data from RCTs of antithrombotic therapy in patients who are critically ill.

Source:

The Lancet Haematology